New Drugs: Oleogel-S10 for Epidermolysis Bullosa
Dr. Ted Rosen discusses the investigational drug oleogel-S10 for epidermolysis bullosa. Ted Rosen, MD, FAAD Professor of Dermatology, Baylor College of Medicine, Houston, Texas Oleogel-S10 (Filsuvez, Amryt) is under consideration by the FDA and approved in the European Union (EU) and Great Britain for the treatment of partial thickness wounds associated with junctional and dystrophic epidermolysis bullosa in […]